Cord blood stem cells saved at birth have offered hope to families faced with life-changing medical conditions once thought untreatable, such as cerebral palsy and autism.
The Philippines is celebrating the 20th anniversary of newborn screening by announcing a further expansion of the program and its goals.
Sub-Saharan Africa has the highest percentage of births with sickle cell disease. Dr. Russell E. Ware and PerkinElmer are collaborating to train African medical technicians to conduct SCD screening on their own.
Climatologists from the University of Milano-Bicocca are employing PerkinElmer’s NexION® 350 SP-ICP-MS to determine elemental contents in some polar ice cores, to help us better understand changes to the environment.
A profile of InfraLeuna and its analytical laboratory, which is among the largest energy producers in Europe.
Profile of the University of Birmingham’s Facility for Environmental Nanoscience Analysis and Characterization and the role played by PerkinElmer.
A couple who lost an infant daughter to a rare metabolic disease is working with PerkinElmer to introduce newborn screening technology to Pakistan.
Profile of Enthalpy Analytical, Inc. and its relationship with PerkinElmer in working towards air quality monitoring solutions for the EPA
Scientists morph stem cells into mini-brains to prove that the Zika virus causes massive brain cell death in fetuses.
How the NexION 350 is expanding Campden BRI's food analysis capabilities.
A profile of how one Big Pharma site is saving big dollars through a single-source provider of laboratory services.
Using high content cellular imaging to engineer new drug therapies to combat human diseases.
Easy-to-use, web-based software platform improves efficiency and accuracy and provides users with near instant access to a world of environmental, regulatory, and business planning data.
Casting a new light on breast cancer
With PerkinElmer’s help, Campden BRI ensures product safety and quality to the food and drink industry.
Seeing Elements Transform At Atomic Scale Unveils A Big Surprise: A Potential New Cancer Therapy
The Netherlands’ RIKILT Institute of Food Safety in Wageningen Is A Global Resource For Safety, Food Analysis Food Fraud Detection, and State-of-the-art Training.
PerkinElmer is instrumental in accelerating the cleanup of Fukushima nuclear disaster.
PerkinElmer teams up with Universiti Tunku Abdul Rahman to test food products for contamination.
Researchers are searching for ways to restore neural function after traumatic brain injuries. Research using human neural stem cells (hNSCs) is showing promise.
After a 2008 disaster with tainted infant formula, Chinese infant formula milk powder producers now have more stringent screening practices they need to follow.
Tsingtao Brewery in China is using headspace sampling to ensure their brews maintain their high quality standards.
Fukushima University builds the first map of radioactive fallout and detects soil contamination to guide cleanup efforts.
PerkinElmer expands its diagnostics portfolio to help China screen its people for HIV/AIDS, HBV, and HCV, 3 of the deadliest infectious diseases in the world.
With the increasing popularity of biofuel blends, new regulations have forced companies to perform quality control at more remote locations.
In therapeutic protein production, the ability to determine the right end-point for mammalian cell culture lets researchers minimize HCP (host-cell protein) contamination.
The NexION® 350 ICP-MS significantly improves the research quality and time needed to detect, quantitate, and characterize nanoparticles.
The European ScreeningPort (ESP) enables academic researchers with promising data on the causes of disease to get physiologically relevant results and help support translating them into potential new therapeutics.
By studying changes in the shape of cells and organelles in response to cancer drugs, researchers hope to pave the way for more effective breast cancer treatments.
Small research facilities combine high-value expertise with high-quality instrumentation to support cell and tissue-based research at Edinburgh University and beyond.